Periodic Reporting for period 1 - QIandQD (The first IVDR-approved commercial software solutions for AI-powered RNA-based companion and precision cancer diagnostics of acute myeloid leukaemia and bladder cancer)

The molecular profiling of tumours is important for providing cancer patients with the correct diagnosis, most effective treatment and accurate prognosis. Next-generation sequencing (NGS)-based technologies are increasingly being included in clinical guidelines as a complement...